Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CDNA | BANF |
|---|---|---|
| Price | $69.85 | $107.57 |
| Change today | ▲ 4.02% | ▼ 0.47% |
| Market cap | $3.61B | $3.61B |
| Return, 3 months | +146.7% | -5.4% |
| Return, year to date | +270.8% | +2.9% |
| Return, 1 year | +366.9% | -13.9% |
| P/E (TTM) | 33.6 | 14.5 |
| P/B | 8.5 | 1.8 |
| P/E percentile vs own 5y | 100th | – |
| Dividend yield | – | 1.82% |
| Revenue growth (YoY, latest qtr) | +13.8% | +10.7% |
| Net profit growth (YoY) | -140.6% | +7.0% |
| Gross margin | 67.6% | – |
| Operating margin | -6.6% | – |
| Net margin | -5.6% | 35.6% |
| Return on equity | -6.3% | – |
| Analyst target vs. price | -10.9% | +14.3% |
| Analyst buy share | 60% | 0% |
| RSI (14) | 84 | 46 |
| 30-day volatility | 50.7% | 17.4% |
| Max drawdown, 1 year | -23.6% | -20.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
